Skip to main content
. Author manuscript; available in PMC: 2022 Feb 4.
Published in final edited form as: Spinal Cord. 2021 Aug 4;59(9):939–947. doi: 10.1038/s41393-021-00665-x

Table 2.

Endorsement rates for IDC

USQNB-IDC Symptom Endorsement Rate (%)
SCI+MS N=314
Bad-smelling, stronger of fouler urine 83.5%
Dark urine 85.4%
Blood in urine 50.3%
Blood clots in urine 35.0%
Cloudy urine 87.3%
Sediments/debris in urine/clogged catheter 78.3%
Bladder spasms 62.6%
Sensation of urinary urgency 34.8%
Urine leakage that isn’t normal 49.0%
Discharge, redness or sensitivity around catheter site 51.1%
Increase or decrease from your usual blood pressure 47.2%
Increased spasticity (not bladder spasms) 46.4%
Sweating 46.4%
Flushing of the chest, neck or face 31.2%
Diarrhea 51.9%
Numbness, tingling in your extremities 37.5%
Sense of burning in the extremities or throughout the body 27.8%
Autonomic Dysreflexia (AD) 46.0%
Felt feverish 42.7%
Fatigue/Lethargy 60.3%
Irritability, mental slowing/confusion 31.5%
Bladder discomfort 37.5%
Pain in the suprapubic region 16.3%
Generalized abdominal discomfort or pain: bloating, pressure or cramping 48.2%
Back pain 40.5%
Pain more than usual below the level of injury 25.1%

NOTES: USQNB-IDC: Urinary Symptom Questionnaire for Neurogenic Bladder or Neurogenic Lower Urinary Tract Dysfunction – for indwelling catheter; SCI=spinal cord injury; MS=multiple sclerosis were analyzed together.